<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00252512</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 03-120</org_study_id>
    <nct_id>NCT00252512</nct_id>
  </id_info>
  <brief_title>The Effect of a Contingency Management Intervention on Substance Use</brief_title>
  <acronym>REAP</acronym>
  <official_title>Effectiveness of Contingency Management in VA Addictions Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Contingency management interventions involve providing a tangible reward for progress toward
      treatment goals. The purpose of this study is to determine whether a contingency management
      intervention added to usual care leads to improved attendance and decreased substance use in
      patients attending outpatient substance use disorders treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: This will be a randomized, controlled trial. 360 veterans presenting for specialty
      substance use disorders treatment at the Minneapolis VAMC and the VA Puget Sound Health Care
      System will be randomly assigned to 8 weeks of Usual Care or Usual Care plus Contingency
      Management. Minimal exclusion criteria include primary cannabis dependence, primary opioid
      dependence, screening positive for pathological gambling, serious psychiatric symptoms or
      suicide risk. Randomization will be stratified by site and primary substance use disorder
      (alcohol or stimulant). All participants will meet with a research assistant twice per week
      to submit urine drug and breath alcohol samples. Participants randomized to the contingency
      management interventions will have the opportunity to draw tokens (with replacement) from a
      bowl each time they submit negative urine drug and breath alcohol screens. The number of
      drawings allowed escalates with continuous weeks of negative screens or returns to baseline
      if screens are positive or missed. Half of the 500 tokens will result in social reinforcement
      (&quot;Good Job!&quot;). The remainder will earn a VA canteen voucher worth monetary value. Follow-up
      assessments occur 2, 6, and 12 months after enrollment into the study. Primary outcomes
      measures include number of days with negative urine drug and breath alcohol screens during
      the intervention phase, days of treatment attendance during the intervention phase, and
      percent days abstinent on the Timeline Follow-Back interview at follow-up assessments.
      Secondary outcomes include a brief assessment of employment, housing, legal, and psychiatric
      status, and administrative data on VA service utilization. A process evaluation and an
      economic analysis are included.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Negative Breath Alcohol and Urine Drug Screens Out of Possible 16</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Psychiatric Status</measure>
    <time_frame>8 weeks, 6 months, 12 months</time_frame>
    <description>Kessler Psychological Distress Scale (K10) - score range 10 to 50.
score under 20 are likely to be well
score 20-24 are likely to have mild psychological distress
score 25-29 are likely to have moderate psychological distress
score 30 and over are likely to have a severe psychological distress</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VHA Healthcare Service Utilization</measure>
    <time_frame>Baseline to 6 month follow up and 6 month follow up to 12 month follow up.</time_frame>
    <description>Cost of total healthcare utilization for six month period between baseline and 6 month follow up and six month period between 6 month and 12 month follow up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Housing</measure>
    <time_frame>8 week, 6 month and 12 month follow-ups</time_frame>
    <description>Number of participants reporting stable housing (owned or rented house, apartment or room)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Legal Status</measure>
    <time_frame>8 weeks, 6 month and 12 month follow ups</time_frame>
    <description>Number of participants reporting detention or incarceration in the previous 30 days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Employment Status</measure>
    <time_frame>8 week, 6 month and 12 month follow up</time_frame>
    <description>Number of participants identifying themselves as unemployed.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">332</enrollment>
  <condition>Substance Use Disorders</condition>
  <arm_group>
    <arm_group_label>Contingency Management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are negative, they receive a chance to draw tokens from a bowl. Some tokens are social reinforcement. Others have monetary value.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency Management</intervention_name>
    <description>Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
    <arm_group_label>Contingency Management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  veterans presenting for outpatient substance use disorders treatment with a diagnosis
             of alcohol, cocaine, amphetamine, or methamphetamine dependence

        Exclusion Criteria:

          -  primary cannabis dependence

          -  primary opioid dependence

          -  severe psychiatric symptoms

          -  suicide risk

          -  positive history or screen for pathological gambling

          -  lacking transportation or living too far away to attend twice per week research
             appointments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hildi J. Hagedorn, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Minneapolis VA Health Care System, Minneapolis, MN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Minneapolis VA Health Care System, Minneapolis, MN</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55417</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System Seattle Division, Seattle, WA</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Hagedorn HJ, Noorbaloochi S, Simon AB, Bangerter A, Stitzer ML, Stetler CB, Kivlahan D. Rewarding early abstinence in Veterans Health Administration addiction clinics. J Subst Abuse Treat. 2013 Jul;45(1):109-17. doi: 10.1016/j.jsat.2013.01.006. Epub 2013 Feb 28.</citation>
    <PMID>23453480</PMID>
  </results_reference>
  <results_reference>
    <citation>Hagedorn HJ, Stetler CB, Bangerter A, Noorbaloochi S, Stitzer ML, Kivlahan D. An implementation-focused process evaluation of an incentive intervention effectiveness trial in substance use disorders clinics at two Veterans Health Administration medical centers. Addict Sci Clin Pract. 2014 Jul 9;9:12. doi: 10.1186/1940-0640-9-12.</citation>
    <PMID>25008457</PMID>
  </results_reference>
  <results_reference>
    <citation>Hagedorn HJ, Noorbaloochi S, Bangerter A, Stitzer ML, Kivlahan D. Health care cost trajectories in the year prior to and following intake into Veterans Health Administration outpatient substance use disorders treatment. J Subst Abuse Treat. 2017 Aug;79:46-52. doi: 10.1016/j.jsat.2017.05.013. Epub 2017 May 25.</citation>
    <PMID>28673526</PMID>
  </results_reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>November 9, 2005</study_first_submitted>
  <study_first_submitted_qc>November 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2005</study_first_posted>
  <results_first_submitted>August 18, 2014</results_first_submitted>
  <results_first_submitted_qc>August 18, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 29, 2014</results_first_posted>
  <last_update_submitted>July 19, 2018</last_update_submitted>
  <last_update_submitted_qc>July 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contingency management interventions</keyword>
  <keyword>Substance use disorders treatment</keyword>
  <keyword>Treatment effectiveness</keyword>
  <keyword>Randomized clinical trial</keyword>
  <keyword>Behavioral research</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Two participants withdrew from participation after random assignment to the placebo condition and did not start the intervention.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Contingency Management</title>
          <description>Contingency Management: Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo: Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="165"/>
                <participants group_id="P2" count="165"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="136"/>
                <participants group_id="P2" count="134"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="31"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Six Month Follow up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="136"/>
                <participants group_id="P2" count="134"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="132"/>
                <participants group_id="P2" count="122"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>12 Month Follow up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="132"/>
                <participants group_id="P2" count="122"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="123"/>
                <participants group_id="P2" count="121"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Contingency Management</title>
          <description>Contingency Management: Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo: Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="165"/>
            <count group_id="B2" value="165"/>
            <count group_id="B3" value="330"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.1" spread="9.7"/>
                    <measurement group_id="B2" value="49.5" spread="8.1"/>
                    <measurement group_id="B3" value="49.3" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="160"/>
                    <measurement group_id="B2" value="163"/>
                    <measurement group_id="B3" value="323"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="162"/>
                    <measurement group_id="B2" value="158"/>
                    <measurement group_id="B3" value="320"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="53"/>
                    <measurement group_id="B3" value="113"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="90"/>
                    <measurement group_id="B2" value="98"/>
                    <measurement group_id="B3" value="188"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="165"/>
                    <measurement group_id="B2" value="165"/>
                    <measurement group_id="B3" value="330"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Negative Breath Alcohol and Urine Drug Screens Out of Possible 16</title>
        <time_frame>8 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Contingency Management</title>
            <description>Contingency Management: Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Negative Breath Alcohol and Urine Drug Screens Out of Possible 16</title>
          <units>negative alcohol and drug screens</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
                <count group_id="O2" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.93" spread="4.67"/>
                    <measurement group_id="O2" value="10.39" spread="5.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;.001</p_value>
            <p_value_desc>Above is calculated p value, a priori threshold for significance set at &lt;.05</p_value_desc>
            <method>GEE full factorial modeling</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Psychiatric Status</title>
        <description>Kessler Psychological Distress Scale (K10) - score range 10 to 50.
score under 20 are likely to be well
score 20-24 are likely to have mild psychological distress
score 25-29 are likely to have moderate psychological distress
score 30 and over are likely to have a severe psychological distress</description>
        <time_frame>8 weeks, 6 months, 12 months</time_frame>
        <population>Fewer participants completed 6 and 12 month follow-up assessments than completed 8 week assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Contingency Management</title>
            <description>Contingency Management: Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
          </group>
        </group_list>
        <measure>
          <title>Psychiatric Status</title>
          <description>Kessler Psychological Distress Scale (K10) - score range 10 to 50.
score under 20 are likely to be well
score 20-24 are likely to have mild psychological distress
score 25-29 are likely to have moderate psychological distress
score 30 and over are likely to have a severe psychological distress</description>
          <population>Fewer participants completed 6 and 12 month follow-up assessments than completed 8 week assessment.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="134"/>
                <count group_id="O2" value="133"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>8 week outcomes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="134"/>
                    <count group_id="O2" value="133"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.87" spread="6.42"/>
                    <measurement group_id="O2" value="18.90" spread="6.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 month outcomes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="131"/>
                    <count group_id="O2" value="120"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20.64" spread="8.31"/>
                    <measurement group_id="O2" value="20.19" spread="7.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month outcomes</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="121"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.06" spread="8.23"/>
                    <measurement group_id="O2" value="19.07" spread="7.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>8 week analysis</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.015</p_value>
            <p_value_desc>a priori threshold of &lt;.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>6 month analysis</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.45</p_value>
            <p_value_desc>a priori threshold of &lt;.05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>12 month analysis</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.0497</p_value>
            <p_value_desc>a prior threshold of .05</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VHA Healthcare Service Utilization</title>
        <description>Cost of total healthcare utilization for six month period between baseline and 6 month follow up and six month period between 6 month and 12 month follow up.</description>
        <time_frame>Baseline to 6 month follow up and 6 month follow up to 12 month follow up.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Contingency Management</title>
            <description>Contingency Management: Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
          </group>
        </group_list>
        <measure>
          <title>VHA Healthcare Service Utilization</title>
          <description>Cost of total healthcare utilization for six month period between baseline and 6 month follow up and six month period between 6 month and 12 month follow up.</description>
          <units>Dollars</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="165"/>
                <count group_id="O2" value="165"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total VHA healthcare costs: baseline-6 month f/up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12744.44" spread="16321.11"/>
                    <measurement group_id="O2" value="16456.32" spread="28113.13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total VHA healthcare costs: 6 month-12 month f/up</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8934.52" spread="13467.21"/>
                    <measurement group_id="O2" value="8386.94" spread="13667.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Costs for period between 6 month follow-up and 12 month follow up.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;.05</p_value>
            <p_value_desc>a priori threshold &lt;.05</p_value_desc>
            <method>Estimation Equation mean modeling</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Costs for period between 6 month follow up and 12 month follow up.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt;.05</p_value>
            <method>Estimating Equation mean modeling</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Housing</title>
        <description>Number of participants reporting stable housing (owned or rented house, apartment or room)</description>
        <time_frame>8 week, 6 month and 12 month follow-ups</time_frame>
        <population>Fewer participants completed 6 and 12 month follow-up assessments than completed 8 week follow up assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Contingency Management</title>
            <description>Contingency Management: Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
          </group>
        </group_list>
        <measure>
          <title>Housing</title>
          <description>Number of participants reporting stable housing (owned or rented house, apartment or room)</description>
          <population>Fewer participants completed 6 and 12 month follow-up assessments than completed 8 week follow up assessment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="132"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Housing status at 8 weeks</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="136"/>
                    <count group_id="O2" value="132"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                    <measurement group_id="O2" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Housing status at 6 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="132"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Housing at 12 months</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="120"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88"/>
                    <measurement group_id="O2" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for 8 week follow up</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.28</p_value>
            <p_value_desc>a priori threshold &lt;.05</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for 6 month follow up</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.013</p_value>
            <p_value_desc>A priori threshold &lt;.05</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for 12 month follow up</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.76</p_value>
            <p_value_desc>A priori threshold &lt;.05</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Legal Status</title>
        <description>Number of participants reporting detention or incarceration in the previous 30 days</description>
        <time_frame>8 weeks, 6 month and 12 month follow ups</time_frame>
        <population>Lower numbers of participants returned for 6 and 12 month follow up assessments compared to 8 week follow up assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Contingency Management</title>
            <description>Contingency Management: Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
          </group>
        </group_list>
        <measure>
          <title>Legal Status</title>
          <description>Number of participants reporting detention or incarceration in the previous 30 days</description>
          <population>Lower numbers of participants returned for 6 and 12 month follow up assessments compared to 8 week follow up assessment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="134"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Legal status at 8 week follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="136"/>
                    <count group_id="O2" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Legal status at 6 month follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="132"/>
                    <count group_id="O2" value="122"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Legal status at 12 month follow up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="123"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for 8 week follow-up</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.66</p_value>
            <p_value_desc>A priori threshold &lt;.05</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for 6 month follow up.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.37</p_value>
            <p_value_desc>A priori threshold &lt;.05</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for 12 month follow up.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.19</p_value>
            <p_value_desc>a priori threshold &lt;.05</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Employment Status</title>
        <description>Number of participants identifying themselves as unemployed.</description>
        <time_frame>8 week, 6 month and 12 month follow up</time_frame>
        <population>Fewer participants completed 6 and 12 month follow up assessments compared to 8 week follow up assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Contingency Management</title>
            <description>Contingency Management: Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo: Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
          </group>
        </group_list>
        <measure>
          <title>Employment Status</title>
          <description>Number of participants identifying themselves as unemployed.</description>
          <population>Fewer participants completed 6 and 12 month follow up assessments compared to 8 week follow up assessment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="136"/>
                <count group_id="O2" value="134"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Employment status at 8 week follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="136"/>
                    <count group_id="O2" value="134"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74"/>
                    <measurement group_id="O2" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Employment status at 6 month follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="132"/>
                    <count group_id="O2" value="122"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Employment status at 12 week follow-up</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="122"/>
                    <count group_id="O2" value="121"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for 8 week follow-up</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.05</p_value>
            <p_value_desc>A priori threshold of &lt;.05</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for 6 month follow-up.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.80</p_value>
            <p_value_desc>A priori threshold of &lt;.05</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis for 12 month follow-up.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.12</p_value>
            <p_value_desc>A priori threshold of &lt;.05</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Contingency Management</title>
          <description>Contingency Management: Participants complete urine and breath screens 2 times per week for 8 weeks. If urine and breath screens are both negative, the participant receives a chance to draw tokens from a bowl. Some tokens are social reinforcement (Good Job!). Other have monetary value.</description>
        </group>
        <group group_id="E2">
          <title>Baseline</title>
          <description>Placebo: Participants complete urine and breath screens 2 times per week for 8 weeks with no reinforcement for negative results.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="49" subjects_at_risk="165"/>
                <counts group_id="E2" subjects_affected="53" subjects_at_risk="165"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="165"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="165"/>
              </event>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="45" subjects_affected="24" subjects_at_risk="165"/>
                <counts group_id="E2" events="39" subjects_affected="26" subjects_at_risk="165"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Hospitalization</sub_title>
                <counts group_id="E1" events="41" subjects_affected="27" subjects_at_risk="165"/>
                <counts group_id="E2" events="45" subjects_affected="30" subjects_at_risk="165"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="165"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="165"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Hildi Hagedorn</name_or_title>
      <organization>Minneapolis VA Health Care System</organization>
      <phone>612-467-3875</phone>
      <email>hildi.hagedorn@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

